Welcome to Neuren
A novel and dynamic biopharmaceutical company developing human therapies for neuroprotection, metabolic disease and growth-related disorders.
Recent announcements
1 July 2009Neuren obtains further US$14m US Army funding
28 May 2009
Chairman's address to 2009 AGM
28 May 2009
AGM presentation